Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

370 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of Risk Factors to Predict the Occurrences of Relapses in Individuals with Schizophrenia Spectrum Disorder in Iran.
Davarinejad O, Mohammadi Majd T, Golmohammadi F, Mohammadi P, Radmehr F, Alikhani M, Motaei T, Moradinazar M, Brühl A, Sadeghi Bahmani D, Brand S. Davarinejad O, et al. Among authors: alikhani m. Int J Environ Res Public Health. 2021 Jan 11;18(2):546. doi: 10.3390/ijerph18020546. Int J Environ Res Public Health. 2021. PMID: 33440817 Free PMC article.
Rosa Damascena oil improved sexual function and testosterone in male patients with opium use disorder under methadone maintenance therapy-results from a double-blind, randomized, placebo-controlled clinical trial.
Farnia V, Tatari F, Alikhani M, Shakeri J, Taghizadeh M, Karbasizadeh H, Sadeghi Bahmani D, Holsboer-Trachsler E, Brand S. Farnia V, et al. Among authors: alikhani m. Drug Alcohol Depend. 2017 Jul 1;176:117-125. doi: 10.1016/j.drugalcdep.2017.02.008. Epub 2017 Apr 6. Drug Alcohol Depend. 2017. PMID: 28531768 Clinical Trial.
Rosa Damascena oil improved methadone-related sexual dysfunction in females with opioid use disorder under methadone maintenance therapy - results from a double-blind, randomized, and placebo-controlled trial.
Farnia V, Tatari F, Alikhani M, Yazdchi K, Taghizadeh M, Sadeghi Bahmani D, Karbasizadeh H, Holsboer-Trachsler E, Brand S. Farnia V, et al. Among authors: alikhani m. J Psychiatr Res. 2017 Dec;95:260-268. doi: 10.1016/j.jpsychires.2017.08.011. Epub 2017 Aug 16. J Psychiatr Res. 2017. PMID: 28923720 Clinical Trial.
Efficacy and tolerability of adjunctive gabapentin and memantine in obsessive compulsive disorder: Double-blind, randomized, placebo-controlled trial.
Farnia V, Gharehbaghi H, Alikhani M, Almasi A, Golshani S, Tatari F, Davarinejad O, Salemi S, Sadeghi Bahmani D, Holsboer-Trachsler E, Brand S. Farnia V, et al. Among authors: alikhani m. J Psychiatr Res. 2018 Sep;104:137-143. doi: 10.1016/j.jpsychires.2018.07.008. Epub 2018 Jul 22. J Psychiatr Res. 2018. PMID: 30044966 Clinical Trial.
Compared to an active control condition, in persons with multiple sclerosis two different types of exercise training improved sleep and depression, but not fatigue, paresthesia, and intolerance of uncertainty.
Sadeghi Bahmani D, Razazian N, Farnia V, Alikhani M, Tatari F, Brand S. Sadeghi Bahmani D, et al. Among authors: alikhani m. Mult Scler Relat Disord. 2019 Nov;36:101356. doi: 10.1016/j.msard.2019.07.032. Epub 2019 Jul 29. Mult Scler Relat Disord. 2019. PMID: 31521917 Clinical Trial.
370 results